U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07692685) titled 'Pharmacokinetic Effect of Y-3 for Injection on Rosuvastatin Calcium Tablets in Healthy Participants' on July 02.
Brief Summary: The primary objective of this study is to evaluate the effect of Y-3 for injection on the pharmacokinetics of rosuvastatin calcium tablets (a sensitive BCRP probe substrate) in healthy participants, in order to assess the potential clinical drug-drug interaction. The results will inform the drafting of the Y-3 for injection package insert and support its safe and rational post-marketing use.
The secondary objectives is to evaluate the effect of Y-3 for injection on the safety of rosuvastatin calcium tablet...